Cheng Ni

State Key Laboratory For Modification Of Chemical Fibers And Polymer Materials
Shanghai, 201620, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Integrated cascade catalysis of AuPtCu nanozymes and glycolysis inhibition for synergistic breast cancer therapy via metabolism regulation.

Integrated cascade catalysis of AuPtCu nanozymes and glycolysis inhibition for synergistic breast cancer therapy via metabolism regulation.

Journal: Biomaterials science

Published: May 18, 2026

Hybrid dextran/fibronectin nanogels for brain-targeted mitophagy inducer delivery to alleviate neuroinflammation and neuronal loss of Parkinson's disease.

Hybrid dextran/fibronectin nanogels for brain-targeted mitophagy inducer delivery to alleviate neuroinflammation and neuronal loss of Parkinson's disease.

Journal: Carbohydrate polymers

Published: February 18, 2026

GPT2-mediated Glutamate to α-Ketoglutaric Acid Conversion in Cardiac Fibroblast Promotes Fibrosis.

GPT2-mediated Glutamate to α-Ketoglutaric Acid Conversion in Cardiac Fibroblast Promotes Fibrosis.

Journal: JACC. Basic to translational science

Published: November 04, 2025

Correction: Dual drug-loaded metal-phenolic networks for targeted magnetic resonance imaging and synergistic chemo-chemodynamic therapy of breast cancer.

Correction: Dual drug-loaded metal-phenolic networks for targeted magnetic resonance imaging and synergistic chemo-chemodynamic therapy of breast cancer.

Journal: Journal of materials chemistry. B

Published: September 08, 2025

Urea cycle fumarate limits fibrosis post-MI by reducing fibroblast mitochondrial ATP production.

Urea cycle fumarate limits fibrosis post-MI by reducing fibroblast mitochondrial ATP production.

Journal: Cardiovascular research

Published: August 04, 2025

Engineered immunosuppressive dendritic cells protect against cardiac remodelling.

Engineered immunosuppressive dendritic cells protect against cardiac remodelling.

Journal: Nature

Published: June 23, 2025

FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1.

FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1.

Journal: Circulation

Published: June 09, 2025

FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity.

FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity.

Journal: Journal of molecular and cellular cardiology

Published: June 08, 2025

FMO2 Promotes Angiogenesis via Regulation of N-Acetylornithine.

FMO2 Promotes Angiogenesis via Regulation of N-Acetylornithine.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 11, 2025

A biomimetic nanoplatform mediates hypoxia-adenosine axis disruption and PD-L1 knockout for enhanced MRI-guided chemodynamic-immunotherapy.

A biomimetic nanoplatform mediates hypoxia-adenosine axis disruption and PD-L1 knockout for enhanced MRI-guided chemodynamic-immunotherapy.

Journal: Acta biomaterialia

Published: April 08, 2025

Atrial fibrillation and flutter as global drivers of heart failure: Burden and longitudinal trends over three decades.

Atrial fibrillation and flutter as global drivers of heart failure: Burden and longitudinal trends over three decades.

Journal: ESC heart failure

Published: March 04, 2025

A functionalized cell membrane biomimetic nanoformulation based on layered double hydroxide for combined tumor chemotherapy and sonodynamic therapy.

A functionalized cell membrane biomimetic nanoformulation based on layered double hydroxide for combined tumor chemotherapy and sonodynamic therapy.

Journal: Journal of materials chemistry. B

Published: July 05, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026